investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Leukaemia

Pathology Hematology and hematologic malignancies

James Y. Chen

Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating

Leukaemia

Charles G Mullighan

Functional analysis of leukemic CREBBP mutations

Leukaemia

Pediatric oncology or childhood cancer

Peter Aplan

Collaborative Pathways that Lead to Leukemia – Rockville

Leukaemia

Pathology Hematology and hematologic malignancies

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Terry Fry

Adoptive T cell Therapy for Pediatric Leukemia

Leukaemia

Pediatric oncology or childhood cancer

George Calin

Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Marc Nicklaus

In Silico Screening for Cancer Targets

Leukaemia

Pathology Hematology and hematologic malignancies

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia